Literature DB >> 24580543

Preferential infiltration of interleukin-4-producing CXCR4+ T cells in the lesional muscle but not skin of patients with dermatomyositis.

T Fujiyama1, T Ito, N Ogawa, T Suda, Y Tokura, H Hashizume.   

Abstract

Dermatomyositis (DM) and polymyositis (PM) are collectively termed autoimmune myopathy. To investigate the difference between muscle- and skin-infiltrating T cells and to address their role for myopathy, we characterized T cells that were directly expanded from the tissues. Enrolled into this study were 25 patients with DM and three patients with PM. Muscle and skin biopsied specimens were immersed in cRPMI medium supplemented with interleukin (IL)-2 and anti-CD3/CD28 antibody-conjugated microbeads. The expanded cells were subjected to flow cytometry to examine their phenotypes. We analysed the cytokine concentration in the culture supernatants from the expanded T cells and the frequencies of cytokine-bearing cells by intracellular staining. There was non-biased in-vitro expansion of tissue-infiltrating CD4(+) and CD8(+) T cells from the muscle and skin specimens. The majority of expanded T cells were chemokine receptor (CCR) type 7(-) CD45RO(+) effecter memory cells with various T cell receptor (TCR) Vβs. The skin-derived but not muscle-derived T cells expressed cutaneous lymphocyte antigen (CLA) and CCR10 and secreted large amounts of IL-17A, suggesting that T helper type 17 (Th17) cells may have a crucial role in the development of skin lesions. Notably, the frequency of IL-4-producing chemokine (C-X-C motif) receptor (CXCR)4(+) Th2 cells was significantly higher in the muscle-derived cells and correlated inversely with the serum creatine phosphokinase (CPK) and lactate dehydrogenase (LDH) levels. stromal-derived factor (SDF)-1/CXCL12, a ligand for CXCR4, was expressed at a high level in the vascular endothelial cells between muscular fasciculi. Our study suggests that T cell populations in the muscle and skin are different, and the Th2 cell infiltrate in the muscle is associated with the low severity of myositis in DM.
© 2014 British Society for Immunology.

Entities:  

Keywords:  CXCR4; IL-4; T cells; dermatomyositis

Mesh:

Substances:

Year:  2014        PMID: 24580543      PMCID: PMC4089160          DOI: 10.1111/cei.12311

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

Review 1.  Polymyositis and dermatomyositis (second of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-20       Impact factor: 91.245

2.  IL-4 acts as a myoblast recruitment factor during mammalian muscle growth.

Authors:  Valerie Horsley; Katie M Jansen; Stephen T Mills; Grace K Pavlath
Journal:  Cell       Date:  2003-05-16       Impact factor: 41.582

3.  Characterization of drug-specific T cells in phenobarbital-induced eruption.

Authors:  Hideo Hashizume; Masahiro Takigawa; Yoshiki Tokura
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

4.  Clonal biases of peripheral CD8 T cell repertoire directly reflect local inflammation in polymyositis.

Authors:  J Nishio; M Suzuki; N Miyasaka; H Kohsaka
Journal:  J Immunol       Date:  2001-10-01       Impact factor: 5.422

5.  Infiltrating cells, related cytokines and chemokine receptors in lesional skin of patients with dermatomyositis.

Authors:  M Caproni; D Torchia; C Cardinali; W Volpi; E Del Bianco; A D'Agata; P Fabbri
Journal:  Br J Dermatol       Date:  2004-10       Impact factor: 9.302

6.  IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis.

Authors:  James G Krueger; Scott Fretzin; Mayte Suárez-Fariñas; Patrick A Haslett; Krista M Phipps; Gregory S Cameron; Juliet McColm; Artemis Katcherian; Inna Cueto; Traci White; Subhashis Banerjee; Robert W Hoffman
Journal:  J Allergy Clin Immunol       Date:  2012-06-05       Impact factor: 10.793

Review 7.  Polymyositis and dermatomyositis.

Authors:  Marinos C Dalakas; Reinhard Hohlfeld
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

8.  Oligoclonal expansion of circulating and tissue-infiltrating CD8+ T cells with killer/effector phenotypes in juvenile dermatomyositis syndrome.

Authors:  K Mizuno; A Yachie; S Nagaoki; H Wada; K Okada; M Kawachi; T Toma; A Konno; K Ohta; Y Kasahara; S Koizumi
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

9.  Localization of the alpha-chemokine SDF-1 and its receptor CXCR4 in idiopathic inflammatory myopathies.

Authors:  Boel De Paepe; J Michael Schröder; Jean-Jacques Martin; Gabor Z Racz; Jan L De Bleecker
Journal:  Neuromuscul Disord       Date:  2004-04       Impact factor: 4.296

Review 10.  CLA(+) T cells in cutaneous diseases.

Authors:  Luis F Santamaria-Babí
Journal:  Eur J Dermatol       Date:  2004 Jan-Feb       Impact factor: 3.328

View more
  6 in total

1.  Elevated IL-4 and IFN-γ Levels in Muscle Tissue of Patients with Dermatomyositis.

Authors:  Murat Giriş; Hacer Durmuş; Berrak Yetimler; Hatice Taşli; Yeşim Parman; Erdem Tüzün
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

Review 2.  Germinal Center-Related G Protein-Coupled Receptors in Antibody-Mediated Autoimmune Skin Diseases: from Basic Research to Clinical Trials.

Authors:  Pengpeng Cao; Ming Yang; Christopher Chang; Haijing Wu; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-08       Impact factor: 8.667

Review 3.  Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.

Authors:  E M Moran; F L Mastaglia
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

4.  Inflammatory milieu of muscle biopsies in juvenile dermatomyositis.

Authors:  Erdal Sag; Gulsev Kale; Goknur Haliloglu; Yelda Bilginer; Zuhal Akcoren; Diclehan Orhan; Safak Gucer; Haluk Topaloglu; Seza Ozen; Beril Talim
Journal:  Rheumatol Int       Date:  2020-10-26       Impact factor: 2.631

5.  Serum levels of interleukins and S100A8/A9 correlate with clinical severity in patients with dermatomyositis-associated interstitial lung disease.

Authors:  Yueyan Lou; Yu Zheng; Bijun Fan; Liyan Zhang; Feng Zhu; Xiaodong Wang; Zhiwei Chen; Xiaoming Tan; Qing Wei
Journal:  BMC Pulm Med       Date:  2020-07-17       Impact factor: 3.317

6.  Expression of the OAS Gene Family Is Highly Modulated in Subjects Affected by Juvenile Dermatomyositis, Resembling an Immune Response to a dsRNA Virus Infection.

Authors:  Giuseppe Musumeci; Paola Castrogiovanni; Ignazio Barbagallo; Daniele Tibullo; Cristina Sanfilippo; Giuseppe Nunnari; Giovanni Francesco Pellicanò; Piero Pavone; Rosario Caltabiano; Roberto Di Marco; Rosa Imbesi; Michelino Di Rosa
Journal:  Int J Mol Sci       Date:  2018-09-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.